Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

Transmucosal Absorption Enhancers in the Drug Delivery Field.

Maher S, Casettari L, Illum L.

Pharmaceutics. 2019 Jul 15;11(7). pii: E339. doi: 10.3390/pharmaceutics11070339.

2.

Intestinal Permeation Enhancers for Oral Delivery of Macromolecules: A Comparison between Salcaprozate Sodium (SNAC) and Sodium Caprate (C10).

Twarog C, Fattah S, Heade J, Maher S, Fattal E, Brayden DJ.

Pharmaceutics. 2019 Feb 13;11(2). pii: E78. doi: 10.3390/pharmaceutics11020078. Review.

3.

Application of Permeation Enhancers in Oral Delivery of Macromolecules: An Update.

Maher S, Brayden DJ, Casettari L, Illum L.

Pharmaceutics. 2019 Jan 19;11(1). pii: E41. doi: 10.3390/pharmaceutics11010041. Review.

4.

Effect of Overencapsulation on the Disintegration and Dissolution of Licensed Formulations for Blinding in Randomized Controlled Trials.

Maher S, Walsh SJ, Takyi J, Wakai A, Brayden DJ, Hayden JC.

J Pharm Sci. 2019 Mar;108(3):1227-1235. doi: 10.1016/j.xphs.2018.10.035. Epub 2018 Oct 29.

PMID:
30385287
5.

Labrasol® and Salts of Medium-Chain Fatty Acids Can Be Combined in Low Concentrations to Increase the Permeability of a Macromolecule Marker Across Isolated Rat Intestinal Mucosae.

Heade J, Maher S, Bleiel SB, Brayden DJ.

J Pharm Sci. 2018 Jun;107(6):1648-1655. doi: 10.1016/j.xphs.2018.02.012. Epub 2018 Feb 17.

PMID:
29462634
6.

Design and Evaluation of Video Podcasts for Providing Online Feedback on Formative Pharmaceutical Calculations Assessments.

Flood M, Hayden JC, Bourke B, Gallagher PJ, Maher S.

Am J Pharm Educ. 2017 Dec;81(10):6400. doi: 10.5688/ajpe6400.

7.

Effects of surfactant-based permeation enhancers on mannitol permeability, histology, and electrogenic ion transport responses in excised rat colonic mucosae.

Maher S, Heade J, McCartney F, Waters S, Bleiel SB, Brayden DJ.

Int J Pharm. 2018 Mar 25;539(1-2):11-22. doi: 10.1016/j.ijpharm.2018.01.008. Epub 2018 Jan 16.

PMID:
29341916
8.

Development of a Non-Aqueous Dispersion to Improve Intestinal Epithelial Flux of Poorly Permeable Macromolecules.

Maher S, Medani M, Carballeira NN, Winter DC, Baird AW, Brayden DJ.

AAPS J. 2017 Jan;19(1):244-253. doi: 10.1208/s12248-016-9996-9. Epub 2016 Oct 13.

PMID:
27739012
9.

Intestinal permeation enhancers for oral peptide delivery.

Maher S, Mrsny RJ, Brayden DJ.

Adv Drug Deliv Rev. 2016 Nov 15;106(Pt B):277-319. doi: 10.1016/j.addr.2016.06.005. Epub 2016 Jun 16. Review.

PMID:
27320643
10.

Sodium caprate-induced increases in intestinal permeability and epithelial damage are prevented by misoprostol.

Brayden DJ, Maher S, Bahar B, Walsh E.

Eur J Pharm Biopharm. 2015 Aug;94:194-206. doi: 10.1016/j.ejpb.2015.05.013. Epub 2015 May 27.

PMID:
26026287
11.

Formulation strategies to improve oral peptide delivery.

Maher S, Ryan B, Duffy A, Brayden DJ.

Pharm Pat Anal. 2014 May;3(3):313-36. doi: 10.4155/ppa.14.15. Review.

PMID:
24998290
12.

Evaluation of alkylmaltosides as intestinal permeation enhancers: comparison between rat intestinal mucosal sheets and Caco-2 monolayers.

Petersen SB, Nolan G, Maher S, Rahbek UL, Guldbrandt M, Brayden DJ.

Eur J Pharm Sci. 2012 Nov 20;47(4):701-12. doi: 10.1016/j.ejps.2012.08.010. Epub 2012 Aug 23.

PMID:
22952065
13.

Oral delivery of macromolecules: rationale underpinning Gastrointestinal Permeation Enhancement Technology (GIPET).

Walsh EG, Adamczyk BE, Chalasani KB, Maher S, O'Toole EB, Fox JS, Leonard TW, Brayden DJ.

Ther Deliv. 2011 Dec;2(12):1595-610. Review.

PMID:
22833984
14.

Chitooligosaccharide elicits acute inflammatory cytokine response through AP-1 pathway in human intestinal epithelial-like (Caco-2) cells.

Bahar B, O'Doherty JV, Maher S, McMorrow J, Sweeney T.

Mol Immunol. 2012 Jul;51(3-4):283-91. doi: 10.1016/j.molimm.2012.03.027. Epub 2012 Apr 16.

PMID:
22512945
15.

High content analysis to determine cytotoxicity of the antimicrobial peptide, melittin and selected structural analogs.

Walsh EG, Maher S, Devocelle M, O'Brien PJ, Baird AW, Brayden DJ.

Peptides. 2011 Aug;32(8):1764-73. doi: 10.1016/j.peptides.2011.06.006. Epub 2011 Jun 15.

PMID:
21703316
16.
17.

Oral absorption enhancement: taking the next steps in therapeutic delivery.

Brayden DJ, Maher S.

Ther Deliv. 2010 Jul;1(1):5-9. No abstract available.

18.

Impact of amino acid replacements on in vitro permeation enhancement and cytotoxicity of the intestinal absorption promoter, melittin.

Maher S, Devocelle M, Ryan S, McClean S, Brayden DJ.

Int J Pharm. 2010 Mar 15;387(1-2):154-60. doi: 10.1016/j.ijpharm.2009.12.022. Epub 2009 Dec 16.

PMID:
20025949
19.

Safety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic.

Maher S, Leonard TW, Jacobsen J, Brayden DJ.

Adv Drug Deliv Rev. 2009 Dec 17;61(15):1427-49. doi: 10.1016/j.addr.2009.09.006. Epub 2009 Oct 1. Review.

PMID:
19800376
20.

Evaluation of intestinal absorption enhancement and local mucosal toxicity of two promoters. I. Studies in isolated rat and human colonic mucosae.

Maher S, Kennelly R, Bzik VA, Baird AW, Wang X, Winter D, Brayden DJ.

Eur J Pharm Sci. 2009 Nov 5;38(4):291-300. doi: 10.1016/j.ejps.2009.09.001. Epub 2009 Sep 6.

PMID:
19737613

Supplemental Content

Loading ...
Support Center